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Abstract
The neurodegenerative disease autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS) is caused by loss of
function of sacsin, a modular protein that is required for normal mitochondrial network organization. To further understand
cellular consequences of loss of sacsin, we performed microarray analyses in sacsin knockdown cells and ARSACS patient
fibroblasts. This identified altered transcript levels for oxidative phosphorylation and oxidative stress genes. These changes
in mitochondrial gene networks were validated by quantitative reverse transcription PCR. Functional impairment of
oxidative phosphorylation was then demonstrated by comparison of mitochondria bioenergetics through extracellular flux
analyses. Moreover, staining with the mitochondrial-specific fluorescent probe MitoSox suggested increased levels of super-
oxide in patient cells with reduced levels of sacsin.
Key to maintaining mitochondrial health is mitochondrial fission, which facilitates the dynamic exchange of mitochondrial
components and separates damaged parts of the mitochondrial network for selective elimination by mitophagy. Fission is
dependent on dynamin-related protein 1 (Drp1), which is recruited to prospective sites of division where it mediates scission.
In sacsin knockdown cells and ARSACS fibroblasts, we observed a decreased incidence of mitochondrial associated Drp1 foci.
This phenotype persists even when fission is induced by drug treatment. Mitochondrial-associated Drp1 foci are also smaller
in sacsin knockdown cells and ARSACS fibroblasts. These data suggest a model for ARSACS where neurons with reduced lev-
els of sacsin are compromised in their ability to recruit or retain Drp1 at the mitochondrial membrane leading to a decline in
mitochondrial health, potentially through impaired mitochondrial quality control.
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Introduction
The neurodegenerative disease autosomal recessive spastic
ataxia of Charlevoix Saguenay (ARSACS: OMIM 270550) was orig-
inally identified in Quebec, but is now known to have a world-
wide distribution (1,2). ARSACS is regarded as the second most
common recessive ataxia and typically presents with a promi-
nent cerebellar ataxia, spasticity and peripheral neuropathy.
Central to ARSACS pathology is Purkinje cell loss, which has
been documented from patient brain and observed in a mouse
model of the disease (3–5).
ARSACS is caused by mutations in the SACS gene that en-
codes sacsin/DNAJC29 (1). At 4579 amino acids in length, sacsin
is one of the largest proteins encoded by the human genome. It
is a modular protein that from N to C terminus is composed of a
ubiquitin-like (UBL) domain that binds to the proteasome (6),
three large sacsin repeat regions (SRR) that may have an Hsp90-
like chaperone function (7), a J-domain that binds Hsp70 (6,8)
and a higher eukaryotes and prokaryotes nucleotide-binding
domain that can dimerize (6–10). Despite the identification of
these domains, sacsin’s cellular role is unknown.
We have previously reported that siRNA-mediated knock-
down of sacsin leads to a reduction in mitochondrial membrane
potential and a more interconnected mitochondrial network in
the SH-SY5Y neuroblastoma cell line (3). Mitochondrial mem-
brane potential was also reduced in Purkinje neurons from sac-
sin knockout mice (3). Subsequently, it has been shown that
mitochondria are elongated and have reduced mobility in motor
neuron cultures from these KO mice (4), whereas in cultured rat
hippocampal neurons transduced with lentivirus encoding
shRNAmiRs targeting sacsin, mitochondria are clustered and
accumulate in the soma and proximal dendrites (3).
There is increasing evidence that perturbation of the equilib-
rium between mitochondrial fission and fusion underlies
mitochondrial defects that contribute to age-related neurode-
generative diseases, including Alzheimer’s and Parkinson’s
(11,12). This is because mitochondrial dynamics are essential
for distribution, traffic, and quality control of mitochondria. For
mitochondrial quality control, fission is required to sequester
damaged parts of mitochondrial networks away from healthy
mitochondria, acting as a precursor to their degradation by
mitophagy (13). Importantly, deficits in mitochondrial fission
may be particularly detrimental in neurons as they have bioen-
ergetic demands at sites distant from the cell body requiring
that they generate mitochondria of the correct size for transport
along dendrites and axons. There is also the possibility that mi-
tochondrial turnover may be restricted to the cell body, as op-
posed to occurring in axons (14), further linking mitochondrial
dynamics and traffic to mitophagy. Moreover, mitochondrial dy-
namics facilitates the exchange of mitochondrial matrix and
membrane components between individual mitochondrion as a
part of mitochondrial network maintenance.
As mitochondrial quality control mechanisms are intrinsi-
cally linked to mitochondrial division, disruption of fission has
potential downstream consequences for important aspects of
mitochondrial function. These include impaired oxidative phos-
phorylation. Unhealthy mitochondria are also likely to accumu-
late reactive oxygen species (ROS) and other markers of
damage. Moreover, there is evidence of reduced mitochondrial
fitness in multiple neurodegenerative diseases. For example, in
Parkinson’s, a disease where the mitochondrial quality control
machinery is compromised, respiration is impaired while ROS
and antioxidant enzymes increase (15,16). Evidence supporting
impaired bioenergetics in Parkinson’s includes that fibroblasts
from patients with sporadic disease show a significant decrease
in respiration compared with controls (17).
The mechanism through which loss of sacsin impairs mito-
chondrial function, distribution, and network organization is
unclear, but could potentially be explained by either an increase
in mitochondrial fusion or a decrease in fission. Supporting a
model where loss of sacsin impairs fission we identified,
through immunoprecipitation, an interaction between the N-
terminal 1368 amino acids of sacsin (encompassing the UBL do-
main and first SRR) and the dynamin-related GTPase dynamin-
related protein 1 (Drp1) (3). During mitochondrial fission Drp1 is
recruited from the cytosol onto the outer mitochondrial mem-
brane (OMM), where it assembles into foci. These foci consist of
oligomeric Drp1 complexes that are thought to wrap around
and constrict the mitochondrial tubule to mediate fission (18).
In this study, we used unbiased microarray and gene ontol-
ogy analyses to identify oxidative phosphorylation and oxida-
tive stress pathways as altered in sacsin knockdown cells
and ARSACS patient fibroblasts. Changes in transcript levels for
genes in these pathways were confirmed by quantitative RT-
PCR (RT-qPCR) in both sacsin knockdown cells and ARSACS pa-
tient fibroblasts. Bioenergetics profiles for cells lacking sacsin
and accumulation of ROS were also analyzed. Using siRNA-me-
diated knockdown and ARSACS patient fibroblast cell lines,
we also examined the effect of reduced cellular levels of sacsin
on Drp1 mitochondrial localization. We identified a reduction
in Drp1 foci at mitochondria and reduced translocation of
Drp1 to mitochondria after ablation of mitochondrial mem-
brane potential. This suggests that sacsin may play a role in re-
cruitment or retention of Drp1 at mitochondrial fission sites,
with loss of this function leading to impaired mitochondrial
health.
Results
Microarray analyses implicate altered mitochondrial
function in ARSACS
To elucidate pathogenic mechanisms of ARSACS, we performed
two microarray experiments using a human Illumina Whole
Genome Gene Expression BeadChip (HT-12 v4.0). We compared
transcript levels in SH-SY5Y cells transfected with siRNAs tar-
geting sacsin and control siRNAs (Supplementary Material,
Figure S1), while in a complimentary experiment, gene expres-
sion profiling was performed to compare ARSACS patient and
control human dermal fibroblasts (HDFs). For this part of the
study, four ARSACS HDF lines and two control HDF lines were
used. ARSACS HDFS were from three compound heterozygous
patients (c.2094-2A>G/Q4054*; K1715*/R4331Q and R2002fs/
Q4054*) and one homozygous patient (2801delQ).
Immunoblotting of lysates from these ARSACS HDF lines was
performed using a commercially available antibody against an
undefined sequence between residues 4100 and 4200 of sacsin.
This detected a sacsin band in cells homozygous for the single
amino acid deletion mutation 2801delQ, which was of similar
intensity to that seen in wild-type control HDFs. In cells with
the K1715*/R4331Q mutation, a significantly fainter sacsin band
was visible. This is consistent with the K1715*/R4331Q HDF line
expressing detectable protein from a single allele. No sacsin
was detected in the other two ARSACS HDF lines although we
could not preclude expression of a truncated protein
(Supplementary Material, Figure S2). In sacsin knockdown cells,
523 genes showed a significant change in expression levels,
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whereas in patient cells, expression of 572 genes was altered
(P< 0.05) (Fig. 1A). Functional annotation clustering using the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) (19), identified enrichment of genes in four
clusters as common to the microarray comparing SH-SY5Y cells
transfected with siRNAs targeting sacsin or scrambled siRNAs
and the microarray comparing ARSACS and control HDFs (Fig.
1B). Two of these clusters related directly to mitochondria with
gene ontology terms including mitochondrial components, cell
respiration, oxidative phosphorylation, and oxidative stress.
From the genes in these groupings, we identified 18 genes
where transcript levels showed a 1-fold or greater upregulation
or downregulation in both the sacsin knockdown cells (Fig. 1C)
and ARSACS HDF cells (Fig. 1D). These included 10 genes that
function in oxidative phosphorylation (NDUFB3, NDUFB8,
NDUFA9, NDUFB9, SDHD, UQCRFS1, COX7B, COX17, ATP5J and
ATP5J2), five genes linked to oxidative stress (SOD2, MAFF, FOSB,
FOS and ATF3) and three genes listed as mitochondrial compo-
nents (SUCLA2, MTCH1 and HSPE1) (Fig. 1D).
Loss of sacsin function causes alterations in levels of
oxidative phosphorylation and oxidative stress gene
transcripts
To validate alterations in transcript levels of oxidative phos-
phorylation and oxidative stress genes, we used RT-qPCR. In an
experiment that was independent from the microarray analy-
ses, total RNA was extracted from sacsin knockdown and con-
trol SH-SY5Y cells. RT-qPCR was then performed for each gene
of interest with raw data normalized to GAPDH levels. In agree-
ment with the microarray data, we observed that expression of
eight oxidative phosphorylation genes were significantly de-
creased in cells with reduced levels of sacsin (Fig. 2A). This in-
cluded genes in each mitochondrial respiratory chain complex,
with COX17 showing the greatest reduction in transcript levels
(>35%). Contrastingly, two oxidative stress genes ATF3 and
FOSB were slightly increased in sacsin knockdown cells al-
though these changes were not significant (Fig. 2B). SOD2, which
the microarray suggested was downregulated, was significantly
upregulated in sacsin knockdown cells. Moreover, the mito-
chondrial component genes (SUCLA2 and MTCH1) that were
identified as having reduced transcript levels in the microarray
experiment were confirmed as being downregulated by RT-
qPCR (Fig. 2C).
Total RNA was also extracted from the four ARSACS patient
HDF cell lines and five control HDF lines and RT-qPCR per-
formed. Again we observed a downregulation of oxidative phos-
phorylation genes (Fig. 2D), with 9 of the 10 genes identified
from the microarray analyses exhibiting significantly decreased
transcript levels in ARSACS HDFs (the exception was SDHD). As
observed in the knockdown experiment, COX17 was the oxida-
tive phosphorylation gene that showed the greatest reduction
in transcript levels (>60%). ARSACS HDFs also exhibited an
upregulation of oxidative stress genes (Fig. 2E) with SOD2, ATF3
and FOSB transcripts all significantly increased relative to con-
trols. The most dramatic change was for FOSB, which showed a
more than 150-fold increase in transcript levels. The mitochon-
drial component genes were also confirmed as downregulated
in the patient cells (Fig. 2F). With the exception of data for SOD2,
changes in gene expression identified by the microarray and
RT-qPCR experiments were in broad agreement. The combined
data from analyses in sacsin knockdown cells and patient HDF
demonstrate reduced expression of oxidative phosphorylation
genes in cellular models of ARSACS and suggests that oxidative
stress is increased.
Bioenergetic parameters are altered in sacsin
knockdown and ARSACS patient cells
Bioenergetics profiling was performed to test for functional con-
sequences of altered mitochondrial gene expression in cells
lacking sacsin. Oxygen consumption rates (OCR) were measured
in SH-SY5Y cells that had previously been transfected with
siRNAs targeting sacsin or control siRNAs (Fig. 3A).
Measurements were made under basal conditions and after se-
quential treatment with the ATP synthase (complex V) inhibitor
oligomycin, followed by the uncoupling agent carbonyl cyanide-
4 (trifluoromethoxy) phenylhydrazone (FCCP). OCR was then de-
termined after mitochondrial respiration was shut down by
combined treatment with the complex I inhibitor rotenone and
the complex III inhibitor antimycin A. These analyses revealed
that basal respiration, ATP production, proton leak, maximal
respiration, and spare capacity were all reduced in SH-SY5Y
cells with reduced levels of sacsin, compared with controls (Fig.
3A and B). These key parameters of mitochondrial respiration
were also compared in ARSACS patient HDF and control HDF
lines. As observed in SH-SY5Y cells with reduced levels of sac-
sin, ARSACS patient HDF showed decreased OCR under basal
conditions and after addition of mitochondrial inhibitors (Fig.
3C and D). Both knockdown cells and HDFs showed a significant
reduction in ATP-coupled respiration and maximal respiration,
strongly suggesting that compromised mitochondrial respira-
tion is a feature of ARSACS.
Increase levels of ROS in ARSACS patient cells
As gene expression analyses suggested increased oxidative
stress in cells with reduced levels of sacsin, we performed stain-
ing with MitoSOX Red to detect superoxide species. Confocal
imaging of HDFs and subsequent measurement of fluorescent
intensity revealed increased levels of MitoSOX staining in
ARSACS patient cells relative to controls, this was confirmed by
quantitative analyses of confocal images (Fig. 4). We were un-
able to validate these findings in sacsin knockdown SH-SY5Y
cells, potentially because the transient knockdown did not re-
duce sacsin levels sufficiently, or for sufficient time, for ROS to
accumulate (not shown).
Localization of Drp1 foci to mitochondria is reduced in
sacsin knockdown cells
The gene expression and functional data presented here sup-
port that mitochondrial health is impaired in ARSACS. Potential
mechanisms for this could include an increase in the proportion
of defective mitochondria in sacsin null cells as a consequence
of impaired mitochondrial dynamics and quality control.
Moreover, ARSACS-associated changes in mitochondrial net-
work organization are consistent with impaired Drp1-mediated
mitochondrial fission (3).
Based on these data, we investigated mitochondrial recruit-
ment of Drp1 in sacsin knockdown cells. Here, we initially used
control HDFs as they have a more distributed mitochondrial
network that was better for quantitative imaging of Drp1 associ-
ation. Cells were transfected with DSRed2-mito along with
scrambled siRNAs or siRNAs targeting SACS. After 48 hours,
cells were fixed and stained for Drp1. First, we confirmed that
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sacsin knockdown in HDFs impacted mitochondrial network or-
ganization, observing that relative to control cells, sacsin knock-
down HDFs frequently exhibited a hyperfused mitochondrial
phenotype indicated by balloon-like or bulbed mitochondria
(Supplementary Material, Figure S3). Interestingly, we also ob-
served a larger total mitochondrial volume in individual cells
transfected with SACS siRNAs relative to controls, suggesting in-
creased mitochondrial mass in response to loss of sacsin
(Supplementary Material, Figure S3). We then analyzed the
number of Drp1 foci localized on individual mitochondria (Fig.
5A and B). We observed that for every 1 mm along the length of a
mitochondrion, an average of 0.816 0.047 Drp1 foci occurred.
This incidence of mitochondrial-associated Drp1 foci
was significantly reduced in sacsin knockdown HDFs, where
only 0.686 0.039 foci localized per 1 mm of mitochondrion.
We next tested whether this observation reflected a reduc-
tion in the capacity of mitochondria in sacsin-deficient cells to
recruit Drp1 to prospective sites of fission (Fig. 5A and B). To in-
duce fission, siRNA-transfected cells were treated with carbonyl
cyanide m-chlorophenyl hydrazine (CCCP), which abolishes
membrane potential across the inner mitochondrial membrane
leading to Drp1-dependent fragmentation of mitochondria and
ultimately mitophagy (20). Confocal imaging indicated exten-
sive mitochondrial fragmentation after CCCP treatment in the
cells transfected with the scrambled siRNA relative to cells
where SACS was targeted (Fig. 5A). The degree of mitochondria
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Figure 1. Microarray analyses identify altered expression of genes associated with mitochondrial function in cells with reduced levels of sacsin. (A) Schematic sum-
mary of microarray study design. Two microarray experiments were performed. The first compared gene expression in SH-SY5Y cells transfected with siRNAs target-
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fragmentation was analyzed by comparing the number of indi-
vidual mitochondrion in cells treated with CCCP and vehicle
controls. This confirmed that CCCP treatment resulted in higher
levels of fragmentation of mitochondrial network in control
HDFs than sacsin knockdown cells (Supplementary Material,
Figure S3). Quantitative analyses identified that treatment with
CCCP resulted in a significant increase in mitochondrial local-
ized Drp1 foci in scrambled siRNA controls (P< 0.0001). The
number of Drp1 foci at mitochondria also increased in
sacsin knockdown cells, but to a lesser degree than for the con-
trol (Fig. 5B). Moreover, sacsin knockdown cells treated with
CCCP still had less mitochondrial localized Drp1 foci than
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Figure 2. RT-qPCR analyses shows cells with reduced levels of sacsin have alterations in levels of oxidative phosphorylation and oxidative stress gene transcripts.
Comparison of transcript levels of oxidative phosphorylation (A), oxidative stress (B), and mitochondrion component (C) genes between SH-SY5Y cells transfected with
siRNAs targeting sacsin and scrambled siRNAs. RT-qPCR was performed on total RNA extracted from five separate knockdown SACS experiments. Transcript levels of
the genes analyzed were normalized to GAPDH levels with data shown as mean fold change relative to cells transfected with scrambled siRNA (SCRM). Statistical sig-
nificances determined by t test are indicated. Comparison of transcript levels of oxidative phosphorylation (D), oxidative stress (E), and mitochondrion component (F)
genes between ARSACS patient and WT control HDFs. RT-qPCR was performed on total RNA extracted from four ARSACS HDF lines and five WT control HDF lines.
Transcript levels of the genes analyzed were normalized to GAPDH levels with data shown as mean fold change relative to WT controls. Statistical significances were
determined by Mann–Whitney U test. Error bars¼SD. *P0.05, **P0.005, ***P0.005.
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control cells that had not been treated to induce fission. This re-
duction in Drp1 recruitment was also confirmed in siRNA-
treated SH-SY5Y cells (Supplementary Material, Figure S4).
As reduced cellular levels of sacsin impaired Drp1 recruit-
ment to mitochondria, we hypothesized that the amount of
Drp1 in individual foci may also be affected. To investigate this
further, we measured the diameter of individual cytosolic and
mitochondrially localized Drp1 foci in control and sacsin knock-
down cells (Fig. 5C and D). In control cells, we observed that cy-
tosolic Drp1 foci were significantly smaller than those localized
to mitochondria (P< 0.0001), with respective diameters of
0.3860.0053 mm and 0.5260.0094 mm. Comparison of the diam-
eter of Drp1 foci between cells transfected with scrambled and
SACS siRNA revealed that mitochondrial associated foci were
16% smaller in cells lacking sacsin (P< 0.0001). In contrast, there
was no significant change in the size of cytosolic Drp1 foci be-
tween control and sacsin knockdown cells. We also measured
the intensity of the Drp1 fluorescent signal for the mitochon-
drial associated Drp1 foci, observing that this was also
significantly reduced in sacsin knockdown cells relative to con-
trols (P< 0.01) (Fig. 5E). To further confirm that Drp1 localization
to mitochondria was reduced upon sacsin knockdown, we ex-
amined levels of the fission factor in mitochondrial fractions
generated from SH-SY5Y cells. Immunoblot analyses of total
cell lysates and mitochondrial fractions further supported re-
duced levels of mitochondrial-associated Drp1 in cells with re-
duced levels of sacsin (Supplementary Material, Figure S4).
A potential explanation for the reduction in mitochondrial-
associated Drp1 was that total levels of the fission factor are re-
duced in sacsin knockdown cells. Immunoblot analyses in SH-
SY5Y suggested that this was not the case, as sacsin knockdown
did not significantly alter total Drp1 levels (Fig. 5F and
Supplementary Material, Figure S4). However, when cells trans-
fected with scrambled siRNAs and siRNAs targeting SACS were
treated with a cross-linking agent before lysates were immuno-
blotted for Drp1, we observed a reduction in higher molecular
weight Drp1 species in sacsin knockdown cells (Fig. 5F and G).
This may reflect an absence of Drp1:sacsin complexes, but could
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Figure 3. Bioenergetic function of mitochondria is impaired in sacsin knockdown and ARSACS patient cells. (A) Comparison of OCR between cells transfected with
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also indicate that Drp1 higher order oligomers or complexes be-
tween Drp1 and other components of the fission machinery are
reduced.
Interestingly, as Drp1-mediated fission may precede removal
of damaged mitochondria by mitophagy, we saw some evidence
for decreased mitochondrial turnover in sacsin knockdown SH-
SY5Y cells. Using the mitochondrial matrix targeted fluorescent
protein MitoTimer (21), we cotransfected a Tet-On SH-SY5Y cell
line with pTRE-tight-MitoTimer and control siRNAs or siRNAs
targeting SACS. Twenty-four hours after transfection, cells were
treated with doxycycline for 1 hour to induce the expression of
the MitoTimer protein. A further 24 and 48 hours after this treat-
ment, cells were imaged and levels of fluorescence were quanti-
fied. This showed a significant greater decrease in MitoTimer
red fluorescence in control cells relative to sacsin knockdown
cells (Supplementary Material, Figure S5).
Localization of Drp1 foci to mitochondria is reduced in
ARSACS patient fibroblasts
As a precursor to investigating Drp1 recruitment in ARSACS
HDFs, we established that altered mitochondrial network mor-
phology was a common feature of all ARSACS patient HDF lines
investigated (Supplementary Material, Figure S6). This was ac-
companied by an increase in total mitochondrial volume per
cell that was significant in two of the ARSACS HDF lines, but not
overall (Supplementary Material, Figure S6). As in sacsin knock-
down cells, we quantified the number of Drp1 foci localized on
individual mitochondria in patient and control lines. This in-
cluded a comparison of the number of Drp1-associated mito-
chondrial foci between vehicle-treated cells and cells treated
with CCCP to induce unopposed Drp1 recruitment (Fig. 6A). We
observed that for all the patient cell lines examined, signifi-
cantly less Drp1 foci were localized to mitochondria than for
control cells (Fig. 6B and Supplementary Material, Figure S7).
ARSACS patient cells also showed a reduced capacity to in-
crease the number of mitochondrial-associated foci after the in-
duction of fission with CCCP. Mitochondrial-associated Drp1
foci were also smaller with a reduced fluorescent intensity
(when detected by immunofluorescent staining for Drp1), rela-
tive to controls (Fig. 6C and D).
In combination, our data in sacsin knockdown cells and
ARSACS HDF lines, indicate that loss of sacsin impairs mito-
chondrial association of Drp1.
Discussion
Data presented here support that decreased mitochondrial
function is a feature of ARSACS. Specifically, we show that oxi-
dative phosphorylation is impaired in cells lacking sacsin, in-
cluding ARSACS patient HDFs. This is also consistent with
decreased expression of nuclear genes encoding respiratory
chain complex components and other mitochondrial proteins.
These observations combined with an increase in expression of
oxidative stress gene transcripts demonstrate that mitochon-
drial health is reduced in ARSACS. This is in agreement with an-
other very recent study that has also reported reduced
bioenergetic function and oxidative stress in ARSACS (22). This
study compared five patient and control HDFs and did not cor-
roborate findings in any cellular models with isogenic controls
(this was a key reason we also performed comparative analyses
in sacsin knockdown cells).
Mitochondrial dynamics are disrupted in ARSACS, with our
data showing that patient HDFs with a range of different
ARSACS mutations have disrupted mitochondrial network orga-
nization. This is consistent with the finding that recruitment of
the fission protein Drp1 to the OMM is reduced in both SACS
knockdown cells and ARSACS patient HDFs. As fission is inte-
gral to mitochondrial quality control, we hypothesize that a fail-
ure to remove damaged mitochondria could explain the
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reduction in mitochondrial respiration and thus contribute to
the molecular pathology of ARSACS. This idea is supported by
our observation that mitochondrial turnover, measured by loss
of MitoTimer fluorescence after a pulse of expression, is re-
duced in sacsin knockdown SH-SY5Y cells. In the context of this
hypothesis, it is important to consider known consequences of
impaired Drp1 function. These include that complete loss of
Drp1 is embryonic lethal in mice, with fibroblasts from these an-
imals having elongated and more interconnected mitochondria
(23,24). In humans Drp1 also appears to be an essential protein
as a mutation at a conserved residue (A359D) in the middle do-
main of Drp1 was neonatal lethal. In this case, fibroblasts again
exhibited a phenotype with mitochondrial elongation with tu-
bular structures concentrated around the nucleus (25). Loss of
sacsin is not embryonic lethal in mice or humans and Drp1 as-
sociation with mitochondria is reduced rather than abolished in
sacsin null cells. This less severe ARSACS phenotype signifies
that sacsin is not essential for Drp1-mediated fission, but may
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be required for normal regulation of mitochondrial division in
some cell types.
This might be more similar to the phenotype in cells de-
pleted for Fis1 and Mff (26). Targeting of these integral OMM
proteins that act as receptors to recruit Drp1 to the mitochon-
drial surface were shown to result in increased mitochondrial
interconnectivity with a reduction in the number and size of mi-
tochondrial associated Drp1 foci. Despite phenotypic overlap, it
seems unlikely that sacsin would function like Fis1 and Mff as a
component of the Drp1 receptor machinery. This is because sac-
sin is a cytosolic protein that localizes at or near the OMM
through an unknown mechanism.
Another possible explanation for the decreased association
of Drp1 to mitochondria in cells with less sacsin is impaired
traffic of Drp1. Modulators of Drp1 distribution include the cyto-
plasmic dynein machinery, with overexpression of the dynactin
subunit, dynamitin (p50), altering mitochondrial dynamics and
reducing the association of Drp1 with mitochondria (27).
It also seems likely that cytoskeletal disorganization more
broadly contributes to the ARSACS mitochondrial phenotype.
Loss of sacsin results in the accumulation of non-
phosphorylated neurofilaments in vulnerable neuronal popula-
tions in SACS-/- mouse and ARSACS patient brain (4). Given that
intermediate filaments, actin microfilaments and microtubules
form an interlinked cytoskeletal network, it is likely that disrup-
tion of neurofilament organization would impact directly on the
distribution of mitochondria and plausibly influence Drp1 dy-
namics. Interestingly, connections between Drp1 mitochondrial
association and cytoskeletal abnormalities have been estab-
lished in animal models of Alzheimer’s disease and related
tauopathies. Specifically, mitochondrial elongation as a conse-
quence of Drp1 mislocalization has been reported in Drosophila
and mouse neurons expressing human tau, with evidence that
this is by a mechanism where phosphorylated tau excessively
stabilizes actin, inhibiting F-actin and myosin-dependent trans-
location of Drp1 and mitochondria, with this contributing to mi-
tochondrial dysfunction and cell death (28).
It is interesting that patient HDFs have detectable cellular
phenotypes, yet ARSACS is purely a neurodegenerative disease.
This supports the hypothesis that abnormal mitochondrial dy-
namics and function is particularly detrimental to neurons.
Explanations of why neurons are highly sensitive to perturba-
tions in mitochondrial dynamics include that they have energy
requirements away from the cell body and must be able to traf-
fic mitochondria relatively long distances (12). For ARSACS, im-
paired traffic is supported by the observation that
mitochondrial motility was significantly reduced in axons of
SACS/mouse motor neurons (4). Clues to potential mecha-
nisms of Purkinje cell death, in response to impaired fission,
come from studies using mouse postmitotic Purkinje cells de-
pleted for Drp1. In these cells, elongated mitochondria ulti-
mately become swollen due to oxidative damage, losing
respiratory function and accumulating markers of degradation.
Moreover, treatment with antioxidants was shown to be neuro-
protective (29). In addition to neurons being particularly vulner-
able to aberrant mitochondrial dynamics, they are reported to
have very limited glycolysis (30). Relative to some other cell
types, this makes neurons more highly dependent on aerobic
oxidative phosphorylation, which our microarray and bioener-
getics data indicate is impaired when sacsin function is lost.
Ultimately, it will be important to analyze the degree of mi-
tochondrial dysfunction associated with ARSACS in neurons. It
is encouraging that ARSACS HDFs have robust and quantifiable
mitochondrial phenotypes, as this suggests that induced
pluripotent stem cell iPSC-derived neurons generated from fi-
broblasts will be a useful and more disease relevant model.
It has previously been found that oxidative phosphorylation
complex assembly and function is modulated by mitochondrial
dynamics, including Drp1 mediated fission (31). Moreover, gene
expression studies have shown that levels of gene transcripts
associated with oxidative phosphorylation, and other aspects of
mitochondrial bioenergetics, are often reduced in neurodegen-
erative disease (32,33). The expression of nuclear genes involved
in mitochondrial function, including those encoding proteins
required for oxidative phosphorylation, is controlled by
mitochondria-to-nucleus signalling mechanisms. These in turn
are modulated by factors such as calcium, ATP and ROS levels
(34). It is thus likely that the changes in gene expression ob-
served in response to loss of sacsin are a consequence of the al-
tered mitochondrial dynamics either directly or more indirectly
through factors such as the accumulation of ROS.
Although we have shown reduced localization of Drp1 to the
OMM contributes to altered mitochondrial dynamics in
ARSACS, the function of sacsin remains unclear. Based on sac-
sin’s repeating structure and large size, one possibility is that it
may have a scaffold function. As sacsin has multiple domains
that link to molecular chaperone and protein degradation sys-
tems, it could potentially tether molecules together in a
chaperone-regulated system. Alternately, sacsin may function
as a chaperone for a specific client or group of client proteins
with the possibility that client protein misfolding affects Drp1-
mediated fission through loss or gain of function. This would be
partly analogous to common neurodegenerative diseases where
both aberrant protein folding and disrupted mitochondrial dy-
namics are features.
Materials and Methods
Cell culture and sacsin knockdown
SH-SY5Y cells were from the American Type Culture Collection
and were grown in Dulbecco’s Minimum Eagle Medium (DMEM)
at a 1:1 ratio with Ham’s F12 medium. Cells were maintained in
medium supplemented with 10% heat-inactivated foetal bovine
serum (FCS) containing 100 U ml1 penicillin and 100 mg ml1
streptomycin. ARSACS patient fibroblasts were a gift from Dr
Sascha Vermeer and colleagues at Radboud University
Nijmegen Medical Centre (Nijmegen, Netherlands). These cells
were collected as a part of a project approved by the Medical
Ethics Committee of the Radboud University (CMO-nr 2014/155).
Written informed consent to participate in this study was ob-
tained from all patients. Control HDFs were purchased from
PromoCell (Heidelberg, Germany) or were kindly provided by Dr
Tristan McKay (Biomedical Sciences, St George’s, University of
London), or Dr Sascha Vermeer. Control and ARSACS HDF lines
used in this work were not closely age or sex matched, but were
all between passage 3 and 8. HDFs were cultured in DMEM sup-
plemented with 10% FBS and 50 U ml1 penicillin and 50 lg ml1
streptomycin (final concentration in media 1%). All cells were
kept in a constant humidified atmosphere of 5% CO2 at 37C.
Cell culture reagents were from Life Technologies (Paisley, UK).
To induce mitochondrial fission cells were treated for 1 hour
with 20 mM CCCP, in their standard culture medium.
For sacsin knockdown a combination of three previously val-
idated siRNAs targeting exons 6 (sense: GGAUGAUCCUC
UGAAGGUC), 7 (sense: GCGGCCGAAUUCUAUAAAG) and 9
(sense: CGUAAGAUUUCUAGAUGAC) of SACS were used (3,6).
These siRNAs were at a concentration of 10 nM each and were
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transfected in combination using Lipofectamine 3000
(ThermoFisher Scientific, Paisley, Scotland), according to the
manufacturers instructions. A negative control siRNA that has
no significant sequence similarity to human gene sequences
was used as a control at a concentration of 30 nM.
Microarrays and RT-qPCR
Total RNA was isolated from SH-SY5Y cells (48 hours post
transfection with siRNAs) or from HDFs using the RNeasy
Mini kit (Qiagen, Hilden, Germany). RNA samples were then
reversed transcribed using the QuantiTect Reverse
Transcription Kit (Qiagen) to give cDNA. Gene expression
profiling using cDNA from SH-SY5Y or HDFs was then per-
formed using a HumanHT-12 v4 Expression BeadChip arrays
(Illumina, San Diego, USA). All arrays were hybridized at
58 C for 16–20 h, followed by wash and stain procedures ac-
cording to the Direct Hybridization Assay Guide (Illumina).
Fluorescent signals were obtained by scanning with iScan
System, and data were extracted with Gene Expression
Module 1.0.6 in GenomeStudio Software 2011.1 (Illumina)
with or without background subtraction. Pathway and ontol-
ogy analysis were performed using DAVID (The Database for
Annotation, Visualization and Integrated Discovery) v6.7,
which enabled functional annotation clustering (19). RT-
qPCR was performed using the MX3000p QPCR Systems
(Agilent, Santa Clara, USA). PCR reactions contained 100 ng of
template cDNA, 200 nM of each gene specific primer, 5 ml of
qPCRBIO SyGreen Mix (PCR Biosystems, London, UK) and
were made to a total volume of 10 ml with ultra-pure water.
Relative gene expression was calculated using the 2(-Delta
Delta C(T)) (DDCT) method where GAPDH was used as the ref-
erence gene (35). That GAPDH transcript levels in sacsin
knockdown SH-SY5Y cells were not significantly different
from controls was confirmed by RT-qPCR using 18S RNA lev-
els for normalization (not shown). PCR conditions and primer
sequence for NDUFB3, NDUFB8, NDUFA9, NDUFB9, SDHD,
UQCRFS1, COX7B, COX17, ATP5J, ATP5J2, SOD2, MAFF, FOSB,
FOS, ATF3, SUCLA2, MTCH1, HSPE1 and GAPDH are available
upon request.
Oxygen consumption rate measurement
Oxygen consumption rate was measured using an XF
Extracellular Flux Analyser (Seahorse Bioscience, MA, USA). SH-
SY5Y and HDFs were seeded at densities of 50 000 and 300 000
cells per well, respectively. Cells were cultured on Seahorse XF-
96 microplates and allowed to grow overnight. On the day of
metabolic flux analysis, cells were changed to unbuffered
DMEM (DMEM base medium supplemented with 10 mM glucose,
1 mM sodium pyruvate, 2 mM L-glutamine, pH 7.4) and incubated
at 37 C in a non-CO2 incubator for 1 hour. All medium and in-
jection reagents were adjusted to pH 7.4 on the day of assay.
Baseline measurements of OCR (measured by oxygen concen-
tration change) and extracellular acidification rate (measured
by pH change) were taken before sequential injection of treat-
ments/inhibitors: oligomycin (ATP synthase inhibitor, 4 mM),
FCCP (mitochondrial respiration uncoupler, 1 mM), and antimy-
cin A (Complex III inhibitor, 1 mM) in conjunction with rotenone
(Complex I inhibitor, 1 mM). Four measurements over time were
collected for each condition with 10–12 replicates per sample.
Data were normalized to protein concentration (measured by
Bradford assay).
Detection of ROS
For detection of ROS, cells were seeded in 35 mm dishes with a
glass insert designed for live cell imaging (MatTek Corporation,
Ashland, USA), They were then stained with MitoSOX Red when
80% confluent. For staining, MitoSOX Red was diluted to a final
concentration of 5 lM solution in phosphate buffer saline (PBS)
containing 100 mM calcium and magnesium (PBS/Ca/Mg). Cells
were washed once in PBS/Ca/Mg prior to MitoSOX addition and
three further times after a 10-minute incubation (at 37C in a 5%
CO2 environment) with the dye. For imaging, dishes were placed
on a 37 C heated stage, and Z-stacks were collected using the
40 objective of a Zeiss LSM510 laser scanning confocal micro-
scope (Zeiss, Jena, Germany). Fluorescent intensity was mea-
sured using the LSM510 Zen software, which allowed for the
measurement of fluorescent intensity within a selected region
of interest. All confocal image acquisition settings were con-
stant throughout the experiment, including for comparison be-
tween patient and control cells.
Immunofluorescent detection and staining
Immunofluorescent staining was as described previously (3).
Briefly, cells cultured on glass coverslips were fixed with 4%
formaldehyde for 15 minutes and then permeablized for 5 min-
utes with 0.2% Triton-X 100. Cells were incubated with primary
antibodies for 2 hours in 0.02% Triton-X100, 1% bovine serum al-
bumin and 10% normal goat serum, prior to washing and incu-
bation with fluorescently labelled secondary antibodies (Alexa
Fluor 488-conjugated goat anti-rabbit or Alexa Fluor 543 conju-
gated goat anti-mouse; ThermoFisher Scientific). Cells were
then counterstained with DAPI and coverslips mounted for mi-
croscopy. Primary antibodies were used at the following titres:
1:500 for rabbit polyclonal anti-Tom20 (Santa Cruz
Biotechnology) and 1:100 for monoclonal anti-Drp1 (BD
Transductions, Oxford, UK). For staining of mitochondria with
MitoTracker (ThermoFisher Scientific), the stock solution was
diluted to a concentration of 100 nM in cell culture media prior
to addition to cells for 30 minutes at 37C in 5% CO2 atmosphere.
After the incubation period, cells were washed twice cell culture
media prior to live imaging or fixation. Confocal microscopy
was performed using a LSM510 with a 63 objective.
Morphometric analyses of mitochondrial networks
Morphometric analyses of mitochondrial network organization
was performed on live cells as described previously (3). For volu-
metric analyses, confocal Z-stacks of MitoTracker stained cells
were collected and used to generate maximum intensity projec-
tions. Surface rendered 3D images generated using the Surpass
module of the Imaris image analysis software (Imaris 7.6.1
Bitplane, Concord, USA) were then used to calculate mitochon-
drial number and volume. Image acquisition settings and
thresholding was consistent across datasets.
Quantitative analyses of Drp1 localization
The number of Drp1 foci per micrometre of mitochondrial
length was determined using the line trace function of the
LSM510 Zen confocal software. Line trace measured the inten-
sity of channel used for detection of mitochondrial and Drp1
fluorescent staining along individual mitochondria. The num-
ber of Drp1 foci along the measured length of mitochondria was
then collated from the graphical and tabular output. Drp1 foci
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intensity and diameter were measured from confocal images
using a combination of the Surpass module and
MeasurementPro modules of Imaris image analysis software.
The mean intensity and diameter of Drp1 were quantified on
randomly chosen mitochondria and in adjacent cytosolic re-
gions in randomly chosen cells from three separate experi-
ments. Area selection was blind to experimental status.
Detection of Drp1 complexes
To study the effect of sacsin knockdown on Drp1 complex for-
mation, SH-SY5Y cells were transfected with either SCRM or
SACS siRNA, and 48 hours post-transfection cells were subjected
to chemical cross-linking. The cleavable, homo-bifunctional
cross-linker dithiobis[succinimidylpropionate] (DSP; Pierce) was
added to the cultured cells and incubated for 1 hour at room
temperature. Cross-linking was stopped by addition of Tris (pH
7.5) to a final concentration of 20 mM. Cells were then lysed and
an equal volume of 2 SDS-PAGE sample buffer, without the re-
ducing agent 2-Mercaptoethanol (2-ME), was added. Drp1 was
detected with monoclonal anti-Drp1 at a titre of 1:500. GAPDH
was also immunoblotted as a loading control with a rabbit anti-
GAPDH at a titre of 1:5000 (Abcam).
Mitochondrial turnover
Tet-On SH-SY5Y cells (a gift from Michael Cheetham, University
College London), grown on glass coverslips, were co-transfected
with pTRE-tight-MitoTimer (21) and control siRNAs or siRNAs
targeting SACS. Twenty-four hours after transfection, cells were
transferred to media containing 2 lg ml1 doxycycline for
1 hour. After 1 hour, doxycycline was removed and cells were
washed before being returned to normal media. Cells were sub-
sequently fixed and prepared for confocal imaging. This was
done 24 and 48 hours after the doxycycline pulse. Confocal Z-
stacks were collected blind to experimental status and levels of
mitochondrial MitoTimer fluorescence analyzed from maxi-
mum intensity projections. Image acquisition settings and
thresholding was consistent across datasets. MitoTimer fluores-
cent protein has a time-dependent transition from green to red
fluorescent emission over time [this has previously been shown
to take 48 hours in HEK-293 cells (21)]. Consistent with this, and
that we achieved a short period of MitoTimer expression, green
fluorescence was not at quantifiable levels at 48 hours post the
doxacycline treatment in control or sacsin knockdown cells.
Statistical analyses
Statistical significance was determined by a Student’s t-test in
the sacsin knockdown dataset and ANOVA or Mann–Whitney U
test in the ARSACS patient HDF dataset.
Supplementary Material
Supplementary Material is available at HMG online.
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